Home/DelSiTech/Kristian Rantala
KR

Kristian Rantala

Chief Financial Officer

DelSiTech

Therapeutic Areas

DelSiTech Pipeline

DrugIndicationPhase
Lead long-acting injectable assetsMetabolic disease and painNot Specified